Keyphrases
Glanders
100%
Melioidosis
100%
Capsular Polysaccharide
100%
Immunization
100%
Glycoconjugates
100%
Polysaccharide-based
100%
Pseudomallei
33%
Protective Antigen
33%
Malleus
16%
Etiological Agents
16%
Burkholderia Pseudomallei
16%
Select Agent
16%
Burkholderia Mallei
16%
Severe Disease
16%
Simple Procedure
16%
Emerging Infectious Diseases
16%
Bacterial Pathogens
16%
Human Vaccines
16%
IgG Response
16%
Biological Warfare
16%
Vaccine Candidate
16%
Infection Diagnosis
16%
Acute Disease
16%
Carrier Protein
16%
T-cell Antigen
16%
Veterinary Vaccines
16%
O-polysaccharide
16%
Biological Terrorism
16%
Carbohydrate Moieties
16%
Infection Treatment
16%
Subunit Vaccine
16%
Virulence Determinants
16%
Chemotherapeutic Interventions
16%
High Titer
16%
Polysaccharide Antigen
16%
Polysaccharide Component
16%
Immunology and Microbiology
Infectious Agent
100%
Vaccine Efficacy
100%
Glycoconjugate
100%
Burkholderia pseudomallei
50%
T Cell
50%
Infectious Disease
50%
Burkholderia mallei
50%
Membrane Transport Protein
50%
Titer
50%
Subunit Vaccine
50%
Pharmacology, Toxicology and Pharmaceutical Science
Glanders
100%
Melioidosis
100%
Polysaccharide
100%
Glycoconjugate
100%
Infectious Agent
28%
Infection
28%
Burkholderia pseudomallei
14%
Disease
14%
Epileptic Absence
14%
Select Agent
14%
Acute Disease
14%
Burkholderia mallei
14%
Veterinary Vaccine
14%
Subunit Vaccine
14%
Carrier Protein
14%
Veterinary Science and Veterinary Medicine
Glanders
100%
Emerging Infectious Disease
33%
T Cell
33%